Page - (000410) - in Biomedical Chemistry: Current Trends and Developments

technologies and bench to bedside translation. Accounts of Chemical Research, 44(10), 1123- 1134. Shima, F., Uto, T., Akagi, T., et al. (2013). Size effect of amphiphilic poly(gamma-glutamic acid) nanoparticles on cellular uptake and maturation of dendritic cells in vivo. Acta Biomaterialia, 9(11), 8894-8901. Shukla-Dave, A., Hricak, H. (2014). Role of mri in prostate cancer detection. NMR in Biomedicine, 27(1), 16-24. Siegel, R., Ma, J., Zou, Z., et al. (2014). Cancer statistics, 2014. CA: A Cancer Journal for Clinicians, 64(1), 9-29. Siegel, R., Ward, E., Brawley, O., et al. (2011). Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: A Cancer Journal for Clinicians, 61(4), 212-236. Signori, E., Iurescia, S., Massi, E., et al. (2010). DNA vaccination strategies for anti-tumour effective gene therapy protocols. Cancer Immunology, Immunotherapy, 59(10), 1583-1591. Silva, J. M., Videira, M., Gaspar, R., et al. (2013). Immune system targeting by biodegradable nanoparticles for cancer vaccines. Journal of Controlled Release, 168(2), 179-199. Singh, M., Chakrapani, A., O’Hagan, D. (2007). Nanoparticles and microparticles as vaccine- delivery systems. Expert Review of Vaccines, 6(5), 797-808. Sloat, B. R., Sandoval, M. A., Hau, A. M., et al. (2010). Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles. Journal of Controlled Release, 141(1), 93-100. Sorkin, A., von Zastrow, M. (2002). Signal transduction and endocytosis: Close encounters of many kinds. Nature Reviews Molecular Cell Biology, 3(8), 600-614. Strebhardt, K., Ullrich, A. (2008). Paul ehrlich’s magic bullet concept: 100 years of progress. Nature Reviews Cancer, 8(6), 473-480. Strieth, S., Eichhorn, M. E., Werner, A., et al. (2008). Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with cisplatin. Clinical Cancer Research, 14(14), 4603-4611. Subbotin, V. M. (2014). Dendritic cell-based cancer immunotherapy: The stagnant approach and a theoretical solution. Drug Discovery Today, 19(7), 834-837. Sultana, S., Khan, M. R., Kumar, M., et al. (2013). Nanoparticles-mediated drug delivery approaches for cancer targeting: A review. Journal of Drug Targeting, 21(2), 107-125. Sumer, B., Gao, J. (2008). Theranostic nanomedicine for cancer. Nanomedicine (Lond), 3(2), 137- 140. Sun, T.-M., Du, J.-Z., Yao, Y.-D., et al. (2011). Simultaneous delivery of sirna and paclitaxel via a “two-in-one” micelleplex promotes synergistic tumor suppression. ACS Nano, 5(2), 1483- 1494. Sun, T., Zhang, Y. S., Pang, B., et al. (2014). Engineered nanoparticles for drug delivery in cancer therapy. Angewandte Chemie International Edition, 53(46), 12320-12364. Sutradhar, K. B., Amin, M. L. (2014). Nanotechnology in cancer drug delivery and selective targeting. ISRN Nanotechnology, 2014(1), 1-12. Tacken, P. J., Zeelenberg, I. S., Cruz, L. J., et al. (2011). Targeted delivery of tlr ligands to human and mouse dendritic cells strongly enhances adjuvanticity. Blood, 118(26), 6836-6844.